semaglutide alzheimer's Oral Ozempic for earlier Alzheimer's? NOPE. "Efficacy and safety of oral 14 mg (flexible dose) in early-stage symptomatic disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials ..." "Interpretation: Semaglutide fails to slow Alzheimer's

Combination therapy with SGLT2 inhibitors + GLP-1 RAs may reduce cardiorenal risk and CV & all-cause mortality in T2D vs SGLT22 inhibitor and GLP-1 RA monotherapy

Thats why theres a lot of excitement around a new pill form of the drug

This contrasts with conventional T2D therapies like sulphonylureas, insulin and thiazolidinediones, which induce weight gain as a by-product of treatment

Scott Harris, M.D., will be discussing the promise of #GLP1/#Glucagon approaches in treating #MASH and #MASLD, as well as the importance of developing therapies tailored to the specific needs of patients with #obesity and/or #MASH

Optimal Weight 5 & 1 Plan Kit

Learn about Noom's GLP-1 Companion in this informative video, offering insight and resources to help close the care gap for your GLP-1 population.